<DOC>
	<DOC>NCT01855984</DOC>
	<brief_summary>The purpose of this study is to determine if tocotrienol supplementation given to school going children with ADHD will result in reduction of their ADHD symptoms.</brief_summary>
	<brief_title>Tocotrienols for School-going Children With ADHD</brief_title>
	<detailed_description>The main objective of the study is to: a. Determine if supplementation of tocotrienol compared to placebo has an effect on the symptoms of school going children with ADHD. The secondary objective is to: 1. Determine if supplementation of tocotrienol compared to placebo has an effect on the dose of current medication used in school going children with ADHD. 2. Determine the safety of tocotrienol in the study population. 3. Determine if tocotrienol levels in children with ADHD correlate with their symptom scores.</detailed_description>
	<mesh_term>Attention Deficit Disorder with Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Tocotrienols</mesh_term>
	<mesh_term>Vitamin E</mesh_term>
	<mesh_term>Tocopherols</mesh_term>
	<criteria>Diagnosed with ADHD in accordance with the Diagnostic and Statistical Manual (DSM) IV criteria. Be able to swallow soft gel capsules. If already on medication for ADHD, the dose of the medication must be stable for the last 3months Be able to attend all follow up visits. Be agreeable to have their teacher score the National Initiative for Children's Healthcare Quality (NICHQ) Vanderbilt Assessment Scale Teacher Informant Be willing to have their blood taken 3 times during the study. ADHD caused by syndromes, inborn errors of metabolism, or structural brain lesions. Coexisting chronic liver disease Current use of anticoagulant or antiplatelet drugs.</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>ADHD</keyword>
	<keyword>Children</keyword>
	<keyword>Tocotrienol</keyword>
</DOC>